Product Details for NDA 022363
LIVALO (PITAVASTATIN CALCIUM)
EQ 1MG BASE
Marketing Status: Prescription
EQ 2MG BASE
Marketing Status: Prescription
EQ 4MG BASE
Marketing Status: Prescription
EQ 1MG BASE
Marketing Status: Prescription
Active Ingredient: PITAVASTATIN CALCIUM
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022363
Product Number: 001
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
LIVALO (PITAVASTATIN CALCIUM)
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022363
Product Number: 001
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 2MG BASE
Marketing Status: Prescription
Active Ingredient: PITAVASTATIN CALCIUM
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022363
Product Number: 002
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
LIVALO (PITAVASTATIN CALCIUM)
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022363
Product Number: 002
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 4MG BASE
Marketing Status: Prescription
Active Ingredient: PITAVASTATIN CALCIUM
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022363
Product Number: 003
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: LIVALO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 4MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022363
Product Number: 003
Approval Date: Aug 3, 2009
Applicant Holder Full Name: KOWA CO LTD
Marketing Status: Prescription
Patent and Exclusivity Information